Australia markets closed

Soleno Therapeutics, Inc. (SLNO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5600-0.1700 (-9.83%)
At close: 04:00PM EDT
1.6200 +0.06 (+3.85%)
After hours: 04:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
-23,417
-30,910
-24,639
-30,774
-13,335
Depreciation & amortisation
1,968
1,963
1,954
1,958
1,963
Deferred income taxes
-
-
-
-
0
Stock-based compensation
2,539
3,276
1,500
825
988
Change in working capital
-1,319
-1,148
2,975
2,499
82
Accounts payable
-930
-235
1,494
1,061
249
Other working capital
-23,276
-27,792
-25,231
-17,396
-11,691
Other non-cash items
-2,742
-443
4,623
1,153
1,002
Net cash provided by operating activities
-23,251
-27,770
-25,224
-17,375
-11,683
Cash flows from investing activities
Investments in property, plant and equipment
-25
-22
-7
-21
-8
Acquisitions, net
-
-
-
-
0
Other investing activities
-
-
-
49
-
Net cash used for investing activities
-25
-22
-7
528
-180
Cash flows from financing activities
Debt repayment
-5
-8
-17
-2
-
Common stock issued
13,766
0
53,722
14,483
16,500
Other financing activities
-16
-120
-
-
-198
Net cash used provided by (used for) financing activities
13,745
-128
53,722
14,481
16,302
Net change in cash
-9,531
-27,920
28,491
-2,366
5,964
Cash at beginning of period
33,596
49,224
20,733
23,099
17,135
Cash at end of period
24,065
21,304
49,224
20,733
23,099
Free cash flow
Operating cash flow
-23,251
-27,770
-25,224
-17,375
-11,683
Capital expenditure
-25
-22
-7
-21
-8
Free cash flow
-23,276
-27,792
-25,231
-17,396
-11,691